Pos1471-HPR Characterisation of the Pathology Attended in the Private Rheumatology Practise in Spain

Background: Rheumatisms are the second most frequent reason for consultation in Europe 1. In Spain, the bulk of prevalence studies exploit public health data 2-3, despite the fact that our health system is mixed. Spanish private health spending reaches 26.7% of the total and is booming 4. However, there is a fundamental lack of studies focused on private care, most of which are local 5-6. Objectives: To characterise the activity performed by rheumatologists in private medicine throughout Spanish geography. Methods: Members of SERPA working group were summoned to participate by email. They were proposed to carry out a detailed study of the diagnoses and diagnostic-therapeutic procedures carried out in usual practise during 4 consecutive weeks, chosen between November 2022 and January 2023. A shared spreadsheet was developed with predefined diagnostics. All diagnoses made were integrated, so that in the presence of several diagnoses in the same patient, 1 point was added to each corresponding category. Approval was obtained from the EC. Results: Out of 274 rheumatologists working in the private area in Spain 7, a total of 21 rheumatologists from 15 different medical centers have participated. During the month of follow-up, a total of 5,214 diagnoses and 431 therapeutic procedures were obtained. The resuts of the most frequent diagnostics are as follows: OP in first place, followed by OA and STP. However, when we unified the diagnoses by type of disease, the I63(4):342-7. 2 Seoane-Mato D, Sánchez-Piedra C, Silva-Fernández L, Sivera F, Blanco FJ, Pérez Ruiz F, et al. Prevalencia de enfermedades reumáticas en población adulta en España (estudio EPISER 2016). Objetivos y metodología. Reumatol Clin. 2019;15(2):90-6. 3 Carmona L, Gabriel R, Ballina J, Laffon A. Proyecto EPISER 2000: prevalencia de enfermedades reumáticas en la población española. Rev Esp Reumatol. 2001;28(1):18-25. 4 Instituto para el Desarrollo e Integración de la Sanidad. Sanidad privada aportando valor. Análisis de situación 2023. 5 Nieto González JC. Reumatología privada ambulatoria, estudio descriptivo en la Comunidad de Madrid. Reumatol Clin. 2019;15(5):e10-3. 6 Alegre C. La Reumatología privada en Cataluña. Reumatol Clin. 2019;15(3):170-2. 7 Yoldi Muñoz B, Gómez Centeno A, Moreno Muelas JV. Estado de la reumatología privada en España. Reumatol Clin. 2017;13(6):313-7. Acknowledgements: NIL. Disclosure of Interests: None declared.